Annual Accounts Payable
$9.46 M
-$5.18 M-35.38%
31 December 2023
Summary:
Innate Pharma SA annual accounts payable is currently $9.46 million, with the most recent change of -$5.18 million (-35.38%) on 31 December 2023. During the last 3 years, it has fallen by -$7.21 million (-43.25%). IPHA annual accounts payable is now -71.05% below its all-time high of $32.69 million, reached on 31 December 2018.IPHA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$9.38 M
-$83.10 K-0.88%
30 June 2024
Summary:
Innate Pharma SA quarterly accounts payable is currently $9.38 million, with the most recent change of -$83.10 thousand (-0.88%) on 30 June 2024. Over the past year, it has dropped by -$83.10 thousand (-0.88%). IPHA quarterly accounts payable is now -71.30% below its all-time high of $32.69 million, reached on 31 December 2018.IPHA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -0.9% |
| 3 y3 years | -43.3% | -43.8% |
| 5 y5 years | -69.8% | - |
IPHA Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.3% | at low | -54.5% | at low |
| 5 y | 5 years | -69.8% | at low | -68.6% | at low |
| alltime | all time | -71.0% | +293.8% | -71.3% | +72.3% |
Innate Pharma SA Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $9.38 M(-0.9%) |
| Dec 2023 | $9.46 M(-35.4%) | $9.46 M(-54.1%) |
| June 2023 | - | $20.64 M(+40.9%) |
| Dec 2022 | $14.64 M(-12.2%) | $14.64 M(+8.5%) |
| June 2022 | - | $13.50 M(-19.0%) |
| Dec 2021 | $16.68 M(-34.6%) | $16.68 M(-17.7%) |
| June 2021 | - | $20.26 M(-20.5%) |
| Dec 2020 | $25.50 M(-18.5%) | $25.50 M(-14.6%) |
| June 2020 | - | $29.85 M(-4.6%) |
| Dec 2019 | $31.29 M(-4.3%) | $31.29 M(+19.0%) |
| June 2019 | - | $26.30 M(-19.5%) |
| Dec 2018 | $32.69 M(+36.4%) | $32.69 M(+29.5%) |
| June 2018 | - | $25.24 M(+5.3%) |
| Dec 2017 | $23.96 M(+45.3%) | $23.96 M(+42.4%) |
| June 2017 | - | $16.82 M(+2.0%) |
| Dec 2016 | $16.49 M | $16.49 M(+37.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $11.99 M(+27.2%) |
| Dec 2015 | $9.42 M(+13.2%) | $9.42 M(+19.9%) |
| June 2015 | - | $7.86 M(-5.6%) |
| Dec 2014 | $8.32 M(+17.3%) | $8.32 M(-36.7%) |
| June 2014 | - | $13.15 M(+85.2%) |
| Dec 2013 | $7.10 M(+14.9%) | $7.10 M(+14.1%) |
| June 2013 | - | $6.22 M(+0.7%) |
| Dec 2012 | $6.18 M(+13.5%) | $6.18 M(-69.8%) |
| June 2012 | - | $20.43 M(+275.4%) |
| Dec 2011 | $5.44 M(-54.5%) | $5.44 M(-35.1%) |
| June 2011 | - | $8.39 M(+5.3%) |
| June 2010 | - | $7.97 M(-33.4%) |
| Dec 2009 | $11.97 M(-11.9%) | $11.97 M |
| Dec 2008 | $13.58 M(-3.8%) | - |
| Dec 2007 | $14.11 M(+13.2%) | - |
| Dec 2006 | $12.47 M(+418.9%) | - |
| Dec 2005 | $2.40 M | - |
FAQ
- What is Innate Pharma SA annual accounts payable?
- What is the all time high annual accounts payable for Innate Pharma SA?
- What is Innate Pharma SA quarterly accounts payable?
- What is the all time high quarterly accounts payable for Innate Pharma SA?
- What is Innate Pharma SA quarterly accounts payable year-on-year change?
What is Innate Pharma SA annual accounts payable?
The current annual accounts payable of IPHA is $9.46 M
What is the all time high annual accounts payable for Innate Pharma SA?
Innate Pharma SA all-time high annual accounts payable is $32.69 M
What is Innate Pharma SA quarterly accounts payable?
The current quarterly accounts payable of IPHA is $9.38 M
What is the all time high quarterly accounts payable for Innate Pharma SA?
Innate Pharma SA all-time high quarterly accounts payable is $32.69 M
What is Innate Pharma SA quarterly accounts payable year-on-year change?
Over the past year, IPHA quarterly accounts payable has changed by -$83.10 K (-0.88%)